Whalegun
Home

Akebia Therapeutics AKBA paid BGR Government Affairs $60K for lobbying in Q2 2026 · Health Issues

Trade details

Type
Lobbying report
Amount
$60,000
Quarter
Q2 2026
Stock
Akebia Therapeutics AKBA
Client
Akebia Therapeutics
Reported
26/07/20

Up 0.0% from last quarter

What else happened in Akebia Therapeutics around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Akebia Therapeutics's other lobbying reports

  • Akebia Therapeutics

    LobbyingAkebia Therapeutics

    $360K

    Reported 07/20

  • Akebia Therapeutics

    LobbyingAkebia Therapeutics

    $60K

    Reported 07/13

  • Akebia Therapeutics

    LobbyingAkebia Therapeutics

    $480K

    Reported 04/20

  • Akebia Therapeutics

    LobbyingAkebia Therapeutics

    $60K

    Reported 04/20

  • Akebia Therapeutics

    LobbyingAkebia Therapeutics

    $45K

    Reported 04/05

Akebia Therapeutics AKBA paid BGR Government Affairs $60K for lobbying in Q2 2026 · Health Issues | Whalegun